Last reviewed · How we verify

NCT07465146

Effects of Minimal and Metabolic Flow Sevoflurane Anesthesia in Gynecological Surgery Patients

Completed Last updated 11 March 2026
What this trial tests

trial testing Low Flow Anesthesia in Low-flow Anesthesia in 97 participants. Completed in 5 February 2025.

Timeline
5 November 2024
Primary endpoint
5 February 2025
5 February 2025

Quick facts

Lead sponsorBaskent University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment97
Start date5 November 2024
Primary completion5 February 2025
Estimated completion5 February 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

Adults 18 to 65, female only, with Low-flow Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to observe the effects of minimal and metabolically required basal anesthetic gas flow rates delivered by the anesthesia workstation under general anesthesia on body temperature, blood pressure, and heart rate during surgery. It also aims to evaluate the impact of reducing excessive delivery of anesthetic gases, air, and oxygen beyond the patient's physiological needs during general anesthesia on minimizing the harmful effects of anesthetic gases on the environment, climate, and global warming, as well as on contributing positively to hospital costs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Low Flow Anesthesia

Trials testing the same drug.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07465146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing